Inovio Pharmaceuticals
INO
#9180
Rank
NZ$0.19 B
Marketcap
NZ$2.80
Share price
3.87%
Change (1 day)
-7.58%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.18 Million. In 2024 the company made an earning of -NZ$0.19 Billion, an increase over its 2023 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion-0.06%
2024 -NZ$0.19 Billion-20.03%
2023 -NZ$0.24 Billion-51.56%
2022 -NZ$0.49 Billion-8.26%
2021 -NZ$0.53 Billion95.4%
2020 -NZ$0.27 Billion36.62%
2019 -NZ$0.2 Billion20.19%
2018 -NZ$0.17 Billion10.94%
2017 -NZ$0.15 Billion9.59%
2016 -NZ$0.14 Billion118.9%
2015 -NZ$61.4 Million-10.67%
2014 -NZ$68.73 Million83.32%
2013 -NZ$37.49 Million
2011 -NZ$38.68 Million15.64%
2010 -NZ$33.45 Million37.7%
2009 -NZ$24.29 Million2.19%
2008 -NZ$23.77 Million-14.09%
2007 -NZ$27.67 Million19.12%
2006 -NZ$23.23 Million9.62%
2005 -NZ$21.19 Million5.77%
2004 -NZ$20.03 Million73.08%
2003 -NZ$11.58 Million12.75%
2002 -NZ$10.27 Million
2000 -NZ$15.54 Million53.93%
1999 -NZ$10.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.38 B-31,140.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.45 B-15,227.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.73 B-9,529.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.04 B-9,163.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.01 B-20,844.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.21 B-9,254.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-NZ$4.79 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$0.60 B-419.30%๐Ÿ‡บ๐Ÿ‡ธ USA